114 related articles for article (PubMed ID: 22212294)
1. Hepatitis B status in migrants and refugees: increasing health burden in Western Australia.
Subramaniam K; Flexman J; Tarquinio L; Thambiran A; Hopkins S; Cheng W
Intern Med J; 2012 Aug; 42(8):880-6. PubMed ID: 22212294
[TBL] [Abstract][Full Text] [Related]
2. The burden of chronic hepatitis B virus infection in Australia, 2011.
MacLachlan JH; Allard N; Towell V; Cowie BC
Aust N Z J Public Health; 2013 Oct; 37(5):416-22. PubMed ID: 24090323
[TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
[TBL] [Abstract][Full Text] [Related]
5. Medical and economic burden of chronic hepatitis B patients at Queen Savang Vadhana Memorial Hospital.
Yeekian C; Geratikornsupak N; Chumpongthong P; Tongsiri S; Dhitavat J; Phonrat B; Pitisuttithum P
J Med Assoc Thai; 2014 Apr; 97(4):447-55. PubMed ID: 24964688
[TBL] [Abstract][Full Text] [Related]
6. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
[TBL] [Abstract][Full Text] [Related]
7. Assessment of chronic hepatitis B: the importance of hepatitis B virus DNA testing.
Croagh CM; Bell SJ; Locarnini S; Desmond PV
Intern Med J; 2012 Feb; 42(2):170-5. PubMed ID: 21241443
[TBL] [Abstract][Full Text] [Related]
8. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
9. The direct cost of managing patients with chronic hepatitis B infection in Australia.
Butler JR; Pianko S; Korda RJ; Nguyen S; Gow PJ; Roberts SK; Strasser SI; Sievert W
J Clin Gastroenterol; 2004; 38(10 Suppl 3):S187-92. PubMed ID: 15602169
[TBL] [Abstract][Full Text] [Related]
10. [Serological and sociodemographic differences in HBV-patients with and without migration background].
Wörmann T; Prüfer-Krämer L; Krämer A
Z Gastroenterol; 2010 May; 48(5):533-41. PubMed ID: 20449785
[TBL] [Abstract][Full Text] [Related]
11. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
Nguyen VT; Razali K; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2008 Jun; 23(6):922-9. PubMed ID: 17608637
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
13. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.
Hu M; Chen W
Value Health; 2009; 12 Suppl 3():S89-92. PubMed ID: 20586991
[TBL] [Abstract][Full Text] [Related]
14. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study].
Fischer C; Mauss S; Zehnter E; Bokemeyer B; Heyne R; Hüppe D
Z Gastroenterol; 2012 Jan; 50(1):22-9. PubMed ID: 22222794
[TBL] [Abstract][Full Text] [Related]
16. Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology.
MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2018 Oct; 42(5):441-443. PubMed ID: 30198602
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of screening immigrants for hepatitis B.
Wong WW; Woo G; Jenny Heathcote E; Krahn M
Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
[TBL] [Abstract][Full Text] [Related]
19. The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.
Allard NL; MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2015 Jun; 39(3):255-9. PubMed ID: 25716519
[TBL] [Abstract][Full Text] [Related]
20. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
